<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>481(11)</volume><submitter>Dean DC</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Liposarcoma is the most commonly diagnosed subtype of soft tissue sarcoma. As these tumors often arise near vital organs and neurovascular structures, complete resection can be challenging; consequently, recurrence rates are high. Additionally, available chemotherapeutic agents have shown limited benefit and substantial toxicities. There is, therefore, a clear and unmet need for novel therapeutics for liposarcoma. Discoidin domain receptor tyrosine kinase 1 (DDR1) is involved in adhesion, proliferation, differentiation, migration, and metastasis in several cancers. However, the expression and clinical importance of DDR1 in liposarcoma are unknown.&lt;h4>Questions/purposes&lt;/h4>The purposes of this study were to assess (1) the expression, (2) the association between DDR1 and </pubmed_abstract><journal>Clinical orthopaedics and related research</journal><pagination>2140-2153</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10567009</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Discoidin Domain Receptor Tyrosine Kinase 1 (DDR1) Is a Novel Therapeutic Target in Liposarcoma: A Tissue Microarray Study.</pubmed_title><pmcid>PMC10567009</pmcid><pubmed_authors>Duan Z</pubmed_authors><pubmed_authors>Hornicek FJ</pubmed_authors><pubmed_authors>Feng W</pubmed_authors><pubmed_authors>Trent JC</pubmed_authors><pubmed_authors>Walker RL</pubmed_authors><pubmed_authors>Dean DC</pubmed_authors><pubmed_authors>Rosenberg AE</pubmed_authors><pubmed_authors>Thanindratarn P</pubmed_authors><pubmed_authors>Temple HT</pubmed_authors></additional><is_claimable>false</is_claimable><name>Discoidin Domain Receptor Tyrosine Kinase 1 (DDR1) Is a Novel Therapeutic Target in Liposarcoma: A Tissue Microarray Study.</name><description>&lt;h4>Background&lt;/h4>Liposarcoma is the most commonly diagnosed subtype of soft tissue sarcoma. As these tumors often arise near vital organs and neurovascular structures, complete resection can be challenging; consequently, recurrence rates are high. Additionally, available chemotherapeutic agents have shown limited benefit and substantial toxicities. There is, therefore, a clear and unmet need for novel therapeutics for liposarcoma. Discoidin domain receptor tyrosine kinase 1 (DDR1) is involved in adhesion, proliferation, differentiation, migration, and metastasis in several cancers. However, the expression and clinical importance of DDR1 in liposarcoma are unknown.&lt;h4>Questions/purposes&lt;/h4>The purposes of this study were to assess (1) the expression, (2) the association between DDR1 and </description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Nov</publication><modification>2025-04-04T03:01:34.313Z</modification><creation>2025-04-04T03:01:34.313Z</creation></dates><accession>S-EPMC10567009</accession><cross_references><pubmed>37768856</pubmed><doi>10.1097/CORR.0000000000002865</doi><doi>10.1097/corr.0000000000002865</doi></cross_references></HashMap>